Valneva is a specialty vaccine company dedicated to advancing vaccines to improve lives. They specialize in the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical needs. Valneva has an impressive portfolio of vaccines in development, including unique vaccines for Lyme disease, COVID-19, and chikungunya.

In addition to their pipeline, Valneva also offers two commercial vaccines for travelers. They are committed to innovation and have a strong focus on research and development for vaccines. Valneva has a proven track record, with expertise in travel health and a strong commitment to Environmental, Social, and Governance (ESG) practices.

Their team is dedicated to delivering high-quality products and services. With a strategic approach and a dedication to bettering lives through vaccines, Valneva is at the forefront of the industry. Their mission is to address major unmet needs in infectious diseases and make a significant impact on global health